Christopher Lee MULLIGAN

Follow

Person

Bordentown, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Immunotherapeutic dosing regimens comprising pomalidomide and an an...
- Patent number 10,925,867
- Issue date Feb 23, 2021
- Bristol-Myers Squibb Company
- Christopher Lee Mulligan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN AN...
- Publication number 20210154183
- Publication date May 27, 2021
- Bristol-Myers Squibb Company
- Christopher Lee Mulligan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN AN...
- Publication number 20180185348
- Publication date Jul 5, 2018
- Bristol-Myers Squibb Company
- Christopher Lee MULLIGAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE